News Update: Sanofi-Aventis Denies Genzyme Acquisition Price Range Rumors
Rate:
11,431 ratings
Views: 213
From: TradeTheTrend
Added: 16 years ago · 0:57 · 480p
Sanofi-Aventis (NYSE:SNY) denied suggestion from Genzyme (NASDAQ:GENZ) that the French drugmaker offered a price range ...
Comments
No comments yet.
